NCT07628283 A Novel Rural Integrated Care and Early Prevention Model for Older Adults at High Risk of or Living With Stroke in China
| NCT ID | NCT07628283 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jiangsu Province (Suqian) Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,510 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,510 participants in total. It began in 2026-06-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This cluster randomized controlled trial aims to evaluate the effectiveness of a novel telemedicine-enabled integrated care model led by rural doctors in reducing cardiovascular and cerebrovascular events among elderly adults (≥65 years) at high risk of stroke in rural China. A total of 39 village clinics will be randomized to either the intervention group (digital health platform-supported integrated care) or the control group (enhanced usual care). The primary outcome is a composite of cardiovascular death, stroke, and hospitalization for heart failure or acute coronary syndrome at 36 months.
Eligibility Criteria
Inclusion Criteria: 1. Aged 65 years or older 2. Rural residents with household registration or long-term residence (≥6 months/year) in the study area 3. High risk of stroke as defined by the National Health Commission's "8+2" stroke risk screening tool: ≥3 risk factors OR history of stroke/TIA 4. Willing to receive long-term health management from the assigned village clinic 5. Written informed consent provided by the participant or their legal representative Exclusion Criteria: 1. Severe dementia or psychiatric disorder that prevents completion of study follow-up and assessments 2. Life expectancy less than 1 year (e.g., advanced malignancy, end-stage renal disease) 3. Currently participating in another interventional clinical trial
Contact & Investigator
Liu Qianghui Director of Suqian Hospital, Jiangsu Provincial People's Hospi
✉ jasonlion815@163.com📞 15951598055
Frequently Asked Questions
Who can join the NCT07628283 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07628283 currently recruiting?
Yes, NCT07628283 is actively recruiting participants. Contact the research team at jasonlion815@163.com for enrollment information.
Where is the NCT07628283 trial being conducted?
This trial is being conducted at Suqian, China, Suqian, China.
Who is sponsoring the NCT07628283 clinical trial?
NCT07628283 is sponsored by Jiangsu Province (Suqian) Hospital. The trial plans to enroll 2,510 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.